The intraocular pressure (IOP) lowering effects of prostaglandins and prostaglandin analogs

MEHMET OKKA

  • Yıl : 2004
  • Cilt : 20
  • Sayı : 1
  •  Sayfa : 47-54
Prostaglandins (PG) are very effective ocular hyper-and hypotensive agents in the mammalian eye, with the direc- tion and magnitude of the intraocular pressure (IOP) change varying by species, PG and dose. İt is generally agreed that these drugs reduce intraocular pressure primarily by increasing uveoscleral outflovv. They may also increase trabecular outflovv facility though available evidence is less convincing. İt has been hypothesized that PGs may increase facility of uveascleral outflow in addition to their other mechanisms, but this has not yet been test- ed. Its potent ocular hypotensive action in primates, including man, Prostaglandin F2 alfa has received substantial study as a potential anti-glaucoma therapeutic agent, but the specific PG receptor(s) involved in ali aspects of the response are unknovvn. In studying prostaglandin and prostaglandin analogs, there are a diverse variety of prostanoid receptor selective agonists. These included DP, EP (EP-ı, EP2 EP3), FP, İP and TP receptor selective compounds.
Atıf yapmak için :
Açıklama : Yazarların hiçbiri, bu makalede bahsedilen herhangi bir ürün, aygıt veya ilaç ile ilgili maddi çıkar ilişkisine sahip değildir. Araştırma, herhangi bir dış organizasyon tarafından desteklenmedi.Yazarlar çalışmanın birincil verilerine tam erişim izni vermek ve derginin talep ettiği takdirde verileri incelemesine izin vermeyi kabul etmektedirler.
The intraocular pressure (IOP) lowering effects of prostaglandins and prostaglandin analogs
, Vol. 20 (1)
Geliş Tarihi : 17.03.2003, Kabul Tarihi : 17.03.2003, Yayın Tarihi : 01.10.2020
Selçuk Tıp Dergisi
ISSN:1017-6616;
E-ISSN:2149-8059;